Claresa Levetan,

MD

Fellow with Distinction, American College of Endocrinology

Founder and Chief Scientific Officer

Bio:

Dr. Levetan was a co-founder of CureDM and lead inventor of a new therapeutic for reversal of type 1 and 2 diabetes that was licensed by Sanofi. Perle Bioscience was developed with the goal of addressing patient needs in a variety of medical conditions that have been considered,"impossible" to tackle.

READ ON

Gil Nathan

Board of Directors

Bio:

Gilbert Nathan received his Bachelor of Science in Management with a major in finance from Tulane University in 2001. After receiving his degree, Mr. Nathan joined Penn Capital Management, an investment manager focused on high yield debt and small cap equities, as a research analyst.

READ ON